NUDT15 and acute lymphoblastic leukemia: Although a possible negative dominant effect of this variant was ruled out, it was shown in a subsequent study in a Japanese population that the combination of rs3765534 with other NUDT15 intermediate activity variants in ALL patients caused intolerance to 6-mercaptopurine and marked leukopenia (38).